CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 189 filers reported holding CRISPR THERAPEUTICS AG in Q2 2019. The put-call ratio across all filers is 1.08 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $1,398,714 | +228.8% | 22,344 | +138.4% | 0.01% | +166.7% |
| Q3 2023 | $425,440 | +6.8% | 9,373 | +32.0% | 0.00% | 0.0% |
| Q2 2023 | $398,538 | +23.5% | 7,099 | -0.5% | 0.00% | +50.0% |
| Q1 2023 | $322,671 | +5.3% | 7,134 | -5.4% | 0.00% | 0.0% |
| Q4 2022 | $306,420 | -35.2% | 7,538 | +4.2% | 0.00% | -66.7% |
| Q3 2022 | $473,000 | -1.9% | 7,232 | -8.8% | 0.01% | 0.0% |
| Q2 2022 | $482,000 | -9.4% | 7,932 | -6.5% | 0.01% | 0.0% |
| Q1 2022 | $532,000 | +14.9% | 8,482 | +38.7% | 0.01% | 0.0% |
| Q4 2021 | $463,000 | -61.4% | 6,115 | -43.0% | 0.01% | -62.5% |
| Q3 2021 | $1,201,000 | +88.2% | 10,733 | +172.1% | 0.02% | +77.8% |
| Q2 2021 | $638,000 | +74.3% | 3,944 | +31.2% | 0.01% | +12.5% |
| Q1 2021 | $366,000 | -55.0% | 3,006 | -43.5% | 0.01% | -57.9% |
| Q4 2020 | $814,000 | +50.2% | 5,317 | -18.0% | 0.02% | +35.7% |
| Q3 2020 | $542,000 | +13.4% | 6,483 | -0.3% | 0.01% | +7.7% |
| Q2 2020 | $478,000 | +136.6% | 6,503 | +36.8% | 0.01% | +85.7% |
| Q1 2020 | $202,000 | -40.8% | 4,752 | -14.7% | 0.01% | -22.2% |
| Q4 2019 | $341,000 | +53.6% | 5,573 | +17.5% | 0.01% | +28.6% |
| Q2 2019 | $222,000 | -57.6% | 4,743 | -60.1% | 0.01% | -61.1% |
| Q3 2018 | $523,000 | -2.4% | 11,873 | +30.8% | 0.02% | -33.3% |
| Q2 2018 | $536,000 | – | 9,080 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $37,781,000 | 20.21% |
| Ariose Capital Management Ltd | 37,900 | $2,872,000 | 6.78% |
| EcoR1 Capital, LLC | 1,077,483 | $81,652,000 | 2.60% |
| NEA Management Company, LLC | 1,590,002 | $120,490,000 | 2.44% |
| ARK Investment Management | 9,087,868 | $688,679,000 | 2.08% |
| NIA IMPACT ADVISORS, LLC | 62,609 | $3,876,000 | 2.06% |
| Deuterium Capital Management, LLC | 18,000 | $1,364,000 | 2.02% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 108,200 | $8,192,000 | 1.82% |
| PLUSTICK MANAGEMENT LLC | 50,000 | $3,789,000 | 1.76% |
| Nikko Asset Management Americas, Inc. | 4,319,471 | $330,526,000 | 1.74% |